http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108295126-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
filingDate 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108295126-B
titleOfInvention Traditional Chinese medicine composition for treating irritable bowel syndrome and preparation method and application thereof
abstract The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating irritable bowel syndrome and a preparation method and application thereof. The prescription has good curative effect on diarrhea IBS, and the total effective rate reaches more than 90%. Not only can improve clinical symptoms of IBS abdominal pain, abdominal distension, diarrhea, vexation and insomnia, incomplete stool and the like, improve the living quality of patients, but also can adjust the abnormal colon motility and the immune function of IBS patients.
priorityDate 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449683544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982

Total number of triples: 35.